Mr Conditional Device Articles & Analysis: Older
2 news found
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever, four-year follow-up data for a MIGS device in an FDA pivotal trial. ...
When placed into the trabecular meshwork and the canal during MIGS, the aqueous drainage device restores the flow of fluid in the eye using a trimodal mechanism of action. ...